Inspire Medical posts first profitable quarter; Q4 revenue $137.9M (+76% YoY) and guides FY2023 $560-570M

Inspire Medical Systems, Inc.

2022-FY EPS reported -$1.60 revenue$407,856,000

Q4 2022 net income $3.2M, diluted EPS $0.10, vs. loss of $2.4M in Q4 2021.
Q4 revenue $137.9M (76% YoY); U.S. revenue $134.3M (+78%), OUS revenue $3.6M (+28%).
Gross margin 83.9% in Q4, down from 85.8% due to inflation and supply chain costs.
Full year 2022 revenue $407.9M (+75% YoY); net loss $44.9M vs. $42.0M in 2021.
FY2023 revenue guidance $560-570M (37-40% growth); expects to add 52-56 new U.S. centers per quarter.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 1.0

Inspire Medical Systems, Inc. reported full year 2023 results: revenue $560 million to $570 million. Guidance initiated.

Period: full year 2023
Revenue: $560 million to $570 million
Guidance: initiated
Result: guidance update

Exact text from the filing

Inspire expects full year 2023 revenue to be in the range of $560 million to $570 million, which would represent growth of approximately 37% to 40% over full year 2022 revenue of $407.9 million.

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 1.0

Inspire Medical Systems, Inc. reported the fiscal year ended December 31, 2022 results: revenue $407.9 million, net income $44.9 million, EPS $1.60.

Period: the fiscal year ended December 31, 2022
Revenue: $407.9 million
Net income: $44.9 million
EPS: $1.60
Result: reported results

Exact text from the filing

Highlights and Full Year 2023 Guidance • Generated revenue of $137.9 million in the fourth quarter of 2022, a 76% increase over the same quarter last year, and revenue of $407.9 million in full year 2022, a 75% increase over full year 2021 • Achieved gross margin of 83.9% in the fourth quarter of 2022 • Reported net income of $3.2 million and diluted net

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 1.0

Inspire Medical Systems, Inc. reported the quarter ended December 31, 2022 results: revenue $137.9 million, net income $3.2 million, EPS $0.10.

Period: the quarter ended December 31, 2022
Revenue: $137.9 million
Net income: $3.2 million
EPS: $0.10
Result: reported results

Exact text from the filing

Revenue was $137.9 million for the three months ended December 31, 2022, a 76% increase from $78.4 million in the corresponding period in the prior year.

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 1.0

Inspire Medical Systems, Inc. updated its the quarter and fiscal year ended December 31, 2022 guidance (reaffirmed).

Period: the quarter and fiscal year ended December 31, 2022
Guidance: reaffirmed
Result: reported results

Exact text from the filing

On February 7, 2023, Inspire Medical Systems, Inc. (the “Company”) issued a press release announcing its financial results for the quarter and fiscal year ended December 31, 2022.

View on SEC.gov

Browse all earnings releases →

Inspire Medical Systems, Inc. filing history →

Source: SEC EDGAR

accession 0001609550-23-000014

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.